Answers are grounded in this paper and cite their sources.
To the Editor:— Orally given methyltestosterone has been used in clinical practice since its introduction by Foss in 1939 (Brit. M. J.2:11, 1939) both for its anabolic and for its androgen effects. It was not until 1947 that Werner (Am. J. Med.3:52, 1947) suggested that its use might rarely be associated with jaundice. Other reports followed (Kinsell, L. W.:Gastroenterology11:672, 1948; Werner, S. C.; Hanger, F. M.; and Kritzler, R. A.:Am. J. Med.8:325, 1950; Wood, J. C.:J. A. M. A.150:1484-1486 [Dec. 13] 1952; Van Dommelen, C. K. V., and Van der Steur, J. C.:Nederl. tijdschr. geneesk.99:2732, 1955; Brick, I. B., and Kyle, L. H.:New England J. Med.246:176, 1952). According to Werner and co-workers (ibid.) the whole picture of jaundice associated with methyltestosterone seems to be due to bile stasis. Biopsy showed dilated
No takes yet. Share an insight, caveat, or question.
Samantha Simpson (1957) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: